Log In
Print
BCIQ
Print
Print this Print this
 

Komboglyze, saxagliptin/metformin (Kombiglyze XR)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionFixed-dose combination of Onglyza saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, plus metformin
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionDipeptidyl peptidase-4 (DPP-4) inhibitor
Latest Stage of DevelopmentMarketed
IndicationDiabetes
Partner

AstraZeneca plc; Otsuka Pharmaceutical Co. Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today